228 related articles for article (PubMed ID: 9687387)
21. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated.
Evans K; Poole K
FEMS Microbiol Lett; 1999 Apr; 173(1):35-9. PubMed ID: 10220878
[TBL] [Abstract][Full Text] [Related]
22. Application of six multiplex PCR's among 200 clinical isolates of Pseudomonas aeruginosa for the detection of 20 drug resistance encoding genes.
Murugan N; Malathi J; Therese KL; Madhavan HN
Kaohsiung J Med Sci; 2018 Feb; 34(2):79-88. PubMed ID: 29413231
[TBL] [Abstract][Full Text] [Related]
23. Interaction of the MexA and MexB components of the MexAB-OprM multidrug efflux system of Pseudomonas aeruginosa: identification of MexA extragenic suppressors of a T578I mutation in MexB.
Nehme D; Poole K
Antimicrob Agents Chemother; 2005 Oct; 49(10):4375-8. PubMed ID: 16189126
[TBL] [Abstract][Full Text] [Related]
24. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa.
Masuda N; Gotoh N; Ohya S; Nishino T
Antimicrob Agents Chemother; 1996 Apr; 40(4):909-13. PubMed ID: 8849250
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
[TBL] [Abstract][Full Text] [Related]
26. The substrate specificity of tripartite efflux systems of Pseudomonas aeruginosa is determined by the RND component.
Murata T; Kuwagaki M; Shin T; Gotoh N; Nishino T
Biochem Biophys Res Commun; 2002 Nov; 299(2):247-51. PubMed ID: 12437977
[TBL] [Abstract][Full Text] [Related]
27. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.
Srikumar R; Li XZ; Poole K
J Bacteriol; 1997 Dec; 179(24):7875-81. PubMed ID: 9401051
[TBL] [Abstract][Full Text] [Related]
28. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.
Kiser TH; Obritsch MD; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627
[TBL] [Abstract][Full Text] [Related]
29. MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region.
Evans K; Adewoye L; Poole K
J Bacteriol; 2001 Feb; 183(3):807-12. PubMed ID: 11208776
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa.
Li XZ; Poole K
J Bacteriol; 2001 Jan; 183(1):12-27. PubMed ID: 11114896
[TBL] [Abstract][Full Text] [Related]
31. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
De Kievit TR; Parkins MD; Gillis RJ; Srikumar R; Ceri H; Poole K; Iglewski BH; Storey DG
Antimicrob Agents Chemother; 2001 Jun; 45(6):1761-70. PubMed ID: 11353623
[TBL] [Abstract][Full Text] [Related]
32. Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa.
Zhao Q; Li XZ; Mistry A; Srikumar R; Zhang L; Lomovskaya O; Poole K
Antimicrob Agents Chemother; 1998 Sep; 42(9):2225-31. PubMed ID: 9736539
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
Purssell A; Poole K
Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
[TBL] [Abstract][Full Text] [Related]
34. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
[TBL] [Abstract][Full Text] [Related]
35. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
[TBL] [Abstract][Full Text] [Related]
36. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
Aeschlimann JR
Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
[TBL] [Abstract][Full Text] [Related]
37. Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa.
Wong KK; Poole K; Gotoh N; Hancock RE
Antimicrob Agents Chemother; 1997 Sep; 41(9):2009-12. PubMed ID: 9303403
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
[TBL] [Abstract][Full Text] [Related]
39. EsrC, an envelope stress-regulated repressor of the mexCD-oprJ multidrug efflux operon in Pseudomonas aeruginosa.
Purssell A; Fruci M; Mikalauskas A; Gilmour C; Poole K
Environ Microbiol; 2015 Jan; 17(1):186-98. PubMed ID: 25143244
[TBL] [Abstract][Full Text] [Related]
40. Role of MexA-MexB-OprM efflux pump system in chronic Pseudomonas aeruginosa pulmonary infection in mice.
Gong F; Zhan W; Wang L; Song Y; Xing M; Song J
J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):546-551. PubMed ID: 22886968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
